Cargando…
Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication
OBJECTIVE: p64MW HPC is a new low-profile flow diverter with reduced thrombogenicity due to hydrophilic coating. The purpose of this study was to evaluate its safety and efficacy in Mongolian patients under dual antiplatelet therapy. METHODS: Consecutive patients with unruptured anterior circulation...
Autores principales: | Petrov, Andrey, Rentsenkhuu, Ganbaatar, Nota, Baatarjan, Ganzorig, Erdenebat, Regzengombo, Boldbat, Jagusch, Sara, Henkes, Elina, Henkes, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874381/ https://www.ncbi.nlm.nih.gov/pubmed/32640858 http://dx.doi.org/10.1177/1591019920939845 |
Ejemplares similares
-
Early clinical experience with the p48MW HPC and p64MW HPC flow
diverters in the anterior circulation aneurysm using single anti-platelet
treatment
por: Bhogal, Pervinder, et al.
Publicado: (2021) -
Use of a p64 MW Flow Diverter with Hydrophilic Polymer Coating (HPC) and Prasugrel Single Antiplatelet Therapy for the Treatment of Unruptured Anterior Circulation Aneurysms: Safety Data and Short-term Occlusion Rates
por: Hellstern, V., et al.
Publicado: (2022) -
The p48_HPC antithrombogenic flow diverter: initial human experience using single antiplatelet therapy
por: Bhogal, Pervinder, et al.
Publicado: (2019) -
Coating (Coating to Optimize Aneurysm Treatment in the New Flow Diverter Generation) study. The first randomized controlled trial evaluating a coated flow diverter (p64 MW HPC): study design
por: Pierot, Laurent, et al.
Publicado: (2023) -
In-stent Stenosis after p64 Flow Diverter Treatment
por: Aguilar Pérez, M., et al.
Publicado: (2017)